Exciting future for Bactiguard with CEO Anders Göransson

Three months have passed since Anders Göransson became CEO of Bactiguard and he speaks with excitement about the future of the company and the growth journey that lays ahead. “Hearing the great feedback from our partners and patients makes me realise that I made the right choice to join Bactiguard”, says Anders Göransson. He shares his...

Bactiguard ranks higher on Allbright’s list of equality

This year Bactiguard has excelled the previous year’s equality ranking from number 57 to 19 among Sweden’s listed companies. Each year Allbright ranks the companies listed on the Stockholm stock market, based on equality, with the most equal companies ranked on the green list. Bactiguard works actively to increase diversity and we are proud...

More than 50% risk reduction of ventilator associated pneumonia with Bactiguard’s Technology

A new study from Liège, Belgium, shows that the usage of Bactiguard’s infection preventive endotracheal tube reduces ventilator associated pneumonia (VAP) with 53% in intensive care patients. The study VITAL was presented in the beginning of October at the European Society of Intensive Care Medicine Congress (ESICM) where it was selected as one...

Sepsis always starts with an infection – causes at least 11 million deaths globally each year.

Sepsis is the number one preventable cause of death in the world, but very few people know what it is and what the consequences are. Every year, around 49 million people suffers from sepsis and 11 million don’t survive. To raise awareness about how to prevent and identify signs of sepsis, World Sepsis Day takes place every year on September...

Healthcare acquired infections increase the mortality during Covid-treatment

Overuse of antibiotics and superbugs could be worsening the Covid-19 pandemic in India, according to an Indian Council of Medical Research (ICMR) study of 10 hospitals. The study showed that more than half of the Covid-19 patients who get a secondary bacterial or fungal infection die. Covid-19 mortality worldwide is 10 %, the subgroup of patients...

This is how Bactiguard helps prevent infections and save lives

Antibiotic resistance is one of the most acute health risks of our time. The threat is often referred to as "the silent tsunami" and could potentially nullify hundreds of years of medical progress, according to the WHO. To counteract the resistance, we need to prevent infections in healthcare and in our everyday lives - a challenge for which the...

46% of critically ill COVID-19 patients developed HAI according to new study

A recent Italian publication has studied hospital-acquired infections (HAI) in critically ill COVID-19 patients. 774 patients with COVID-19 treated at intensive care unit (ICU) at 8 hospitals in Italy were included. The publication1 shows that 46 % of the critically ill COVID-19 patients developed HAI, of which 38 % were caused by multi-drug...

Continued exemptions to slow the spread of infection

The Swedish Chemicals Agency has decided on a continued exemption to secure access to disinfectants in Sweden due to the corona pandemic. The exemptions apply to disinfectants which, among other things, contain hydrogen peroxide or active chlorine as mechanism of action. The Swedish Chemicals Agency assesses that there is a risk that there will...